title: Ciliochoroidal effusion syndrome associated with posterior scleritis.
abstract: BACKGROUND
  To determine the cause of angle-closure glaucoma in a case of posterior scleritis.
  
  
  METHODS
  The patient was a 65-year-old woman with unilateral acute angle-closure glaucoma who did not respond to laser iridotomy.
  
  
  METHODS
  Slit-lamp examination demonstrated a shallow anterior chamber in the left eye. Intraocular pressure was 22 mmHg even after application of two antiglaucoma eye-drop preparations. B-scan ultrasonography demonstrated scleral thickening and choroidal detachment in the left eye. Ultrasound biomicroscopy showed a shallow anterior chamber with angle closure, annular ciliochoroidal effusion with ciliary body edema, and an anterior rotation of the ciliary body. After instillation of cycloplegics, the ciliary body and ciliary processes rotated posteriorly, resulting in the release of the pressure on the iris. These changes led to the opening of the angle and subsequent normalization of intraocular pressure. A diagnosis was made of ciliochoroidal effusion syndrome associated with posterior scleritis.
  
  
  CONCLUSIONS
  Patients with posterior scleritis can develop ciliochoroidal effusion syndrome, which can lead to angle-closure glaucoma. The therapeutic strategy for acute angle-closure glaucoma induced by ciliochoroidal effusion syndrome differs completely from that for acute angle-closure glaucoma with pupillary block. In the case of ciliochoroidal effusion syndrome, it is important to relieve the compression of the angle by the iris by displacing the lens-iris diaphragm posteriorly by cycloplegics.
authors.affiliation: Department of Ophthalmology, Hyogo College of Medicine, Hyogo, Japan. nao-i@hyo-med.ac.jp
authors.forename: Naohiro
authors.initials: N
authors.lastname: Ikeda
authors.forename: Tomohiro
authors.initials: T
authors.lastname: Ikeda
authors.forename: Chika
authors.initials: C
authors.lastname: Nomura
authors.forename: Osamu
authors.initials: O
authors.lastname: Mimura
mesh_terms: D000208:Acute Disease; D000368:Aged; D001285:Atropine / Q000627:therapeutic use; D001623:Betamethasone / Q000627:therapeutic use; D015862:Choroid Diseases / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology*; D002924:Ciliary Body / Q000000981:diagnostic imaging / Q000187:drug effects / Q000473:pathology*; D003519:Cyclopentolate / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004487:Edema / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology*; D005260:Female; D015812:Glaucoma, Angle-Closure / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D007429:Intraocular Pressure; D008776:Methylprednisolone Hemisuccinate / Q000627:therapeutic use; D015423:Scleritis / Q000150:complications* / Q000000981:diagnostic imaging / Q000188:drug therapy; D013577:Syndrome; D014057:Tomography, X-Ray Computed; D014463:Ultrasonography; D014603:Uveal Diseases / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology*
chemical_list: D008776:Methylprednisolone Hemisuccinate; D001285:Atropine; D001623:Betamethasone; D003519:Cyclopentolate